Fujian Aonong Biological Technology Group Incorporation (603363.SH) plans to reduce their holdings by a total of up to 894,400 shares.
Aonong Biology (603363.SH) announced that in order to meet its own funding requirements, Mr. Wu Youcai plans to raise funds through a concentration...
Fujian Aonong Biological Technology Group Incorporation (603363.SH) announced that Mr. Wu Youcai plans to reduce his holdings in the company by no more than 794,000 shares (0.0305% of the total share capital) through centralized bidding or block trading to meet his own funding needs. Mr. Guo Qinghui plans to reduce his holdings in the company by no more than 100,100 shares (0.0038% of the total share capital) through centralized bidding. The reduction period is within 3 months after 15 trading days from the announcement date of the reduction plan.
Related Articles
Guangdong Shaoneng Group shareholder Shenzhen Zhaowei plans to reduce its holdings by no more than 3%.
IMMUNOTECH-B (06978): Cao Ran appointed as non-executive director.
Shenzhen Energy Group (000027.SZ) plans to invest 10 million yuan in the Shenzhen Investment Holding Corporation East China Sea New Energy Industry Fund.
Guangdong Shaoneng Group shareholder Shenzhen Zhaowei plans to reduce its holdings by no more than 3%.
IMMUNOTECH-B (06978): Cao Ran appointed as non-executive director.
Shenzhen Energy Group (000027.SZ) plans to invest 10 million yuan in the Shenzhen Investment Holding Corporation East China Sea New Energy Industry Fund.
RECOMMEND
